Piper Jaffray Companies restated their buy rating on shares of Henry Schein (NASDAQ:HSIC) in a research note issued to investors on Wednesday morning. The firm currently has a $78.00 price target on the stock.
Other equities analysts have also recently issued research reports about the company. Craig Hallum upgraded Henry Schein from a hold rating to a buy rating in a report on Tuesday, November 7th. UBS Group reiterated a buy rating on shares of Henry Schein in a report on Friday, September 15th. Robert W. Baird set a $95.00 price target on Henry Schein and gave the company a buy rating in a report on Thursday, October 19th. Deutsche Bank started coverage on Henry Schein in a report on Friday, December 8th. They issued a buy rating and a $79.00 price target on the stock. Finally, TheStreet cut Henry Schein from a b rating to a c+ rating in a report on Monday, November 6th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the stock. Henry Schein has an average rating of Hold and an average price target of $86.21.
Shares of Henry Schein (HSIC) opened at $69.88 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.86 and a current ratio of 1.55. The company has a market capitalization of $10,967.94, a price-to-earnings ratio of 19.60, a PEG ratio of 1.97 and a beta of 0.99. Henry Schein has a 1-year low of $65.28 and a 1-year high of $93.50.
Henry Schein declared that its Board of Directors has initiated a share buyback program on Monday, September 18th that authorizes the company to buyback $400.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.3% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.
In other Henry Schein news, Director Barry J. Alperin sold 5,796 shares of the firm’s stock in a transaction dated Friday, December 1st. The stock was sold at an average price of $70.76, for a total transaction of $410,124.96. Following the transaction, the director now owns 48,172 shares in the company, valued at $3,408,650.72. The sale was disclosed in a document filed with the SEC, which is available through this link. 1.19% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Intrust Bank NA boosted its holdings in Henry Schein by 1.1% during the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock worth $223,000 after buying an additional 13 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its holdings in Henry Schein by 0.3% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock worth $1,079,000 after buying an additional 19 shares during the last quarter. YorkBridge Wealth Partners LLC boosted its holdings in Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after buying an additional 28 shares during the last quarter. Sawtooth Solutions LLC boosted its holdings in Henry Schein by 2.4% during the second quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock worth $247,000 after buying an additional 32 shares during the last quarter. Finally, State of Tennessee Treasury Department boosted its holdings in Henry Schein by 0.3% during the second quarter. State of Tennessee Treasury Department now owns 21,697 shares of the company’s stock worth $3,971,000 after buying an additional 66 shares during the last quarter. Hedge funds and other institutional investors own 91.69% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was published by Community Financial News and is the property of of Community Financial News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.com-unik.info/2017/12/31/henry-schein-hsic-earns-buy-rating-from-piper-jaffray-companies.html.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.